Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 10 studies | 25% ± 10% | |
adipocyte | 10 studies | 28% ± 10% | |
astrocyte | 6 studies | 30% ± 9% | |
epithelial cell | 5 studies | 35% ± 11% | |
abnormal cell | 4 studies | 33% ± 17% | |
basal cell | 4 studies | 22% ± 3% | |
ciliated cell | 4 studies | 25% ± 4% | |
extravillous trophoblast | 3 studies | 39% ± 9% | |
macrophage | 3 studies | 19% ± 2% | |
pericyte | 3 studies | 37% ± 14% | |
connective tissue cell | 3 studies | 28% ± 15% | |
endothelial cell | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 93% | 3757.51 | 429 / 459 | 98% | 51.12 | 1099 / 1118 |
ovary | 78% | 2519.75 | 140 / 180 | 94% | 25.81 | 405 / 430 |
bladder | 76% | 2527.14 | 16 / 21 | 96% | 64.55 | 482 / 504 |
skin | 90% | 2139.20 | 1628 / 1809 | 74% | 17.40 | 349 / 472 |
lung | 65% | 2952.61 | 377 / 578 | 83% | 47.20 | 959 / 1155 |
brain | 47% | 1106.58 | 1231 / 2642 | 84% | 40.54 | 591 / 705 |
uterus | 34% | 564.66 | 58 / 170 | 93% | 50.36 | 428 / 459 |
kidney | 49% | 2119.61 | 44 / 89 | 78% | 187.93 | 701 / 901 |
esophagus | 56% | 3816.72 | 807 / 1445 | 67% | 20.77 | 123 / 183 |
intestine | 28% | 645.33 | 269 / 966 | 87% | 38.64 | 457 / 527 |
stomach | 33% | 706.79 | 118 / 359 | 71% | 30.82 | 203 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 57.06 | 1 / 1 |
adipose | 99% | 5778.04 | 1190 / 1204 | 0% | 0 | 0 / 0 |
prostate | 33% | 718.45 | 81 / 245 | 65% | 10.96 | 326 / 502 |
tonsil | 0% | 0 | 0 / 0 | 84% | 32.40 | 38 / 45 |
pancreas | 13% | 204.97 | 42 / 328 | 70% | 23.74 | 125 / 178 |
blood vessel | 70% | 3509.99 | 928 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 19.52 | 20 / 29 |
thymus | 42% | 741.51 | 275 / 653 | 25% | 4.40 | 152 / 605 |
peripheral blood | 62% | 7149.27 | 572 / 929 | 0% | 0 | 0 / 0 |
liver | 29% | 1101.23 | 65 / 226 | 17% | 4.80 | 68 / 406 |
heart | 37% | 1397.46 | 315 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 13% | 253.68 | 33 / 258 | 13% | 3.13 | 31 / 230 |
spleen | 6% | 235.64 | 15 / 241 | 0% | 0 | 0 / 0 |
muscle | 5% | 69.64 | 37 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.50 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0010884 | Biological process | positive regulation of lipid storage |
GO_0035425 | Biological process | autocrine signaling |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0030141 | Cellular component | secretory granule |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005811 | Cellular component | lipid droplet |
GO_0016020 | Cellular component | membrane |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HILPDA |
Protein name | Hypoxia-inducible lipid droplet-associated protein (Hypoxia-inducible gene 2 protein) |
Synonyms | C7orf68 HIG2 |
Description | FUNCTION: Increases intracellular lipid accumulation. Stimulates expression of cytokines including IL6, MIF and VEGFA. Enhances cell growth and proliferation. . |
Accessions | ENST00000257696.5 ENST00000435296.2 Q9Y5L2 |